Literature DB >> 6605969

The T8 antigen is a multimeric complex of two distinct subunits on human thymocytes but consists of homomultimeric forms on peripheral blood T lymphocytes.

P M Snow, C Terhorst.   

Abstract

Monoclonal antibodies allow for the detection of structures on the cell surface of human cytotoxic thymus-derived lymphocytes, which are involved in their function. Among these cell surface components, T8 is of particular interest, since it is required during the recognition of target cells by a subset of human cytotoxic T lymphocytes. The only other cell types on which T8 has been detected are functionally inert thymocytes. Here we demonstrate that T8 isolated from peripheral blood T lymphocytes is different from thymocyte T8. On peripheral blood T lymphocytes T8 was found in multimeric forms of a 34-kDa glycoprotein. These forms were also found on thymocytes, but in addition multimeric complexes of the 34-kDa T8 with a 46-kDa protein were detected. Preliminary chemical analyses showed that the 34-kDa and the 46-kDa forms differ in both their protein and carbohydrate structures. The 46-kDa structure was found to be distinct from the major thymocyte antigen T10. The interchain disulfide bridges between the 34-kDa T8 polypeptide are located in the 24-kDa CNBr fragment, which contains a hydrophobic region. Two (14 kDa and 20 kDa) of the three CNBr fragments of the 46-kDa T8 subunit were found to be involved in interchain disulfide bridging with the 34-kDa T8 species. We suggest that the switch from heteromultimers to homomultimers may occur concomitantly with the last step in T lymphocyte maturation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605969

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase.

Authors:  A S Shaw; J Chalupny; J A Whitney; C Hammond; K E Amrein; P Kavathas; B M Sefton; J K Rose
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

Review 2.  T-cell clones and T-cell receptors.

Authors:  F W Fitch
Journal:  Microbiol Rev       Date:  1986-03

3.  Characterization by a monoclonal antibody and functional analysis of a subset of bovine T lymphocytes that express BoT8, a molecule analogous to human CD8.

Authors:  J A Ellis; C L Baldwin; N D MacHugh; A Bensaid; A J Teale; B M Goddeeris; W I Morrison
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

4.  Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation.

Authors:  M Tagawa; H Nakauchi; L A Herzenberg; G P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  CD8B, the human equivalent of the mouse Ly-3 gene is localized on chromosome 2.

Authors:  N K Spurr; P N Goodfellow; P Johnson
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Surface antigens, SBU-T4 and SBU-T8, of sheep T lymphocyte subsets defined by monoclonal antibodies.

Authors:  J F Maddox; C R Mackay; M R Brandon
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

7.  Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes.

Authors:  Y Bushkin; S Demaria; J M Le; R Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase.

Authors:  C Zong; R Yan; A August; J E Darnell; H Hanafusa
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

9.  A human homolog of the mouse CD8 molecule, Lyt-3: genomic sequence and expression.

Authors:  P Johnson
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Phosphorylation and down-regulation of CD4 and CD8 in human CTLs and mouse L cells.

Authors:  J P DiSanto; J S Klein; N Flomenberg
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.